0.50 / AMA PRA Category 1 Credit(s)TM
Physicians may be hesitant to apply a patient-tailored approach to multiple myeloma treatment, especially with respect to the selection of optimal therapy combinations and sequences that integrate new agents aimed at maximizing treatment response and survival. This symposium will address practical applications of an individualized approach to management of patients with multiple myeloma. Case-based and panel discussions will focus on strategies to combine patient-, disease-, and cytogenetic-specific factors to assess risk, define prognosis, and select therapies for newly diagnosed and relapsed/refractory disease that result in maximal response rate and duration.
This scientific program is designed to meet the current educational needs of hematologists-oncologists and medical oncologists involved in the care of patients with multiple myeloma.
After taking part in this educational activity, participants have an improved ability to:
Penn State College of Medicine and Curatio CME Institute adhere to ACCME Essential Areas, Standards for Commercial Support, and Policies regarding industry support of continuing medical education. It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and the program sponsors have a process in place to resolve any conflict of interest. Complete disclosure is provided below under the Faculty subheading below. Speakers are also required to openly disclose discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine, Curatio CME Institute, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Penn State College of Medicine, the Multiple Myeloma Research Foundation, Celgene Corporation, Millennium: The Takeda Oncology Company, or Onyx Pharmaceuticals do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Penn State College of Medicine, the Multiple Myeloma Research Foundation, Celgene Corporation, Millennium: The Takeda Oncology Company, and Onyx Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 80% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can then access at any time.
For questions regarding the content of this activity, please contact firstname.lastname@example.org.
Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course #G5356-14-T.
If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.